Fred Meyer #603 Durable Medical Equipment & Medical Supplies Location: 301e Wallace Kneeland Blvd, Shelton, Washington 98584 Phone: (360) 432-5373 |
Safeway Pharmacy #0585 Durable Medical Equipment & Medical Supplies Location: 600 W Franklin St, Shelton, Washington 98584 Phone: (360) 426-0718 |
The Medicine Shoppe #106 Community/Retail Pharmacy Location: 207 Professional Way, Shelton, Washington 98584 Phone: (360) 426-4272 |
Walmart Pharmacy 10-2121 Durable Medical Equipment & Medical Supplies Location: 100 E Wallace Kneeland Blvd, Shelton, Washington 98584 Phone: (360) 427-0171 |
News Archive
Protein Sciences Corporation announced today that Astellas Pharma has submitted an application for marketing approval of recombinant influenza HA vaccine ASP7374 (marketed as FlublokĀ® in the United States by Protein Sciences) to the Ministry of Health, Labour and Welfare in Japan for the prevention of influenza.
World Vision will join seven other aid agencies today to begin a massive distribution of food provided by the World Food Program. The distribution effort, with support of the Haitian Government, is expected to reach some 1.6 million people throughout Port-au-Prince, some living in volatile areas that have so far received little aid.
Former professional football players with large bodies don't appear to have the same risk factors for heart disease as their non-athletic counterparts, UT Southwestern Medical Center researchers have found in studying a group of National Football League (NFL) alumni.
Socially disadvantaged mothers who receive home visits from trained community visitors are less likely to deliver low birth weight babies than other mothers in similar circumstances, a new study finds.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
› Verified 4 days ago